The litigation is currently in the discovery phase, with both sides exchanging documents, medical records, and expert reports
If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
However, further research in humans is still needed to confirm its effectiveness.
Xenograft volumes were measured on the indicated days ( b )
Every 34 hours, check in: Does my body need energy? If yes, take a few intentional bites
Restoring Cytokine Balance in HIV-Positive Individuals With Low Cd4 T Cell Counts